Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 21,781 CGEM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 21,781 | n/a |
| Aug 8, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 79,456 | n/a |
| Jul 1, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 660,000 | n/a |
| Jun 26, 2024 | Gritstone bio, Inc. (GRTS) | Gift | 325,000 | n/a |
| May 17, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 47,873 | n/a |
| Feb 5, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 105,000 | n/a |
| Jul 5, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 73,212 | n/a |
| Jul 3, 2023 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 500,000 | n/a |